Brain damage is possible even after a single dose. The EMA has ordered the immediate recall of the drugs.
⚠️ This Claim Is Real—But the Headline Needs Context There is a recent European Medicines Agency (EMA) safety action that matches much of this claim, involving levamisole-containing medicines. In March 2026, the EMA recommended withdrawing levamisole medicines from the EU market after an EU-wide review confirmed a rare but serious adverse effect called leukoencephalopathy, which …









